Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Why Every Medical Affairs Team Needs Their Own AI Agent in 2025

48:31
 
Share
 

Manage episode 498657223 series 3446111
Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator).
Learn how AI in biotech is tackling the complexities of medical affairs—from literature review and content automation to compliance and regulatory writing.
⚡️ WHAT YOU’LL LEARN:
- Why medical affairs and regulatory teams can’t rely on ChatGPT alone.
- How MACg integrates real‑time PubMed search, citation generation, and secured collaboration to streamline scientific writing
- Why MACg users report up to 50 % faster writing and 50–70 % faster medical-legal review.
- Why AI platforms like MACg must be purpose-built for life sciences (GDPR & SOC 2 compliant).
- What is “human-in-the-loop” AI workflow—and how it balances automation and review to maintain accuracy and trust.
- Real-world use cases: scientific summaries, medical info letters and more.
🎙️ Guest: Ome Ogbru | Founder and President of AINGENS
🔗 Connect with Ome: LinkedIn

For transcripts, check out the podcast website - www.lifesciencespod.com

  continue reading

Chapters

1. Intro and Ome's background (00:00:00)

2. From pharma layoffs to launching AINGENS (00:03:15)

3. What makes MACg life‑science safe vs. ChatGPT (00:08:30)

4. Case study: streamlining safety reports & HCP letters (00:15:45)

5. AI hallucinations in drug‑safety vs. compliance (00:22:00)

6. Designing human‑in‑the‑loop pipelines for trust & auditability (00:28:50)

7. Why 2025 is THE year for AI in medical affairs (00:35:00)

8. Advice if you’re running a biotech or MA ops team (00:42:15)

9. Future: MACg agents, fine‑tuning for safety protocols (00:50:00)

86 episodes

Artwork
iconShare
 
Manage episode 498657223 series 3446111
Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator).
Learn how AI in biotech is tackling the complexities of medical affairs—from literature review and content automation to compliance and regulatory writing.
⚡️ WHAT YOU’LL LEARN:
- Why medical affairs and regulatory teams can’t rely on ChatGPT alone.
- How MACg integrates real‑time PubMed search, citation generation, and secured collaboration to streamline scientific writing
- Why MACg users report up to 50 % faster writing and 50–70 % faster medical-legal review.
- Why AI platforms like MACg must be purpose-built for life sciences (GDPR & SOC 2 compliant).
- What is “human-in-the-loop” AI workflow—and how it balances automation and review to maintain accuracy and trust.
- Real-world use cases: scientific summaries, medical info letters and more.
🎙️ Guest: Ome Ogbru | Founder and President of AINGENS
🔗 Connect with Ome: LinkedIn

For transcripts, check out the podcast website - www.lifesciencespod.com

  continue reading

Chapters

1. Intro and Ome's background (00:00:00)

2. From pharma layoffs to launching AINGENS (00:03:15)

3. What makes MACg life‑science safe vs. ChatGPT (00:08:30)

4. Case study: streamlining safety reports & HCP letters (00:15:45)

5. AI hallucinations in drug‑safety vs. compliance (00:22:00)

6. Designing human‑in‑the‑loop pipelines for trust & auditability (00:28:50)

7. Why 2025 is THE year for AI in medical affairs (00:35:00)

8. Advice if you’re running a biotech or MA ops team (00:42:15)

9. Future: MACg agents, fine‑tuning for safety protocols (00:50:00)

86 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play